Upcoming Allied Market Research
Alcoholic Hepatitis Therapeutics Market

Alcoholic Hepatitis Therapeutics Market

Global Opportunity Analysis and Industry Forecast 2022-2029

Report Code: A11500
Pages: NA
Nov 2022 | 625 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Alcoholic Hepatitis Therapeutics Market

Request Now !

Alcoholic hepatitis is referred as an acute but destructive form of liver disease that is characterized by increased bilirubin level. The normal bilirubin level for a healthy adult is 1.2 mg/dl whereas the bilirubin level in alcoholic hepatitis is over 10-15 mg/dl. The symptoms for the disease include loss of appetite, nausea, abnormal tenderness, low grade fever, fatigue, weakness, malnutrition, fluid accumulation in abdomen part, behavioral changes, confusion, and kidney and liver failure. The cause of alcoholic hepatitis is higher intake of alcohol. Some of the extensively used drugs for treatment of alcoholic hepatitis therapeutics include pentoxifylline, nutritional therapy, anabolic steroids and other hemorheological agents. The alcoholic hepatitis has the following symptoms like belly tenderness or pain over the liver, nausea, vomiting blood, poor appetite, yellowing of the skin and eyes, weight loss, tiredness and weakness, fever. The goal of the treatment follows the restoration of some or all functioning of the liver. There is no proper treatment medicine to cure alcoholic hepatitis. The available treatment only involves easing the symptoms and keeping the disease from getting worse.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Increase in popularity of the alcoholic hepatitis disease like cirrhosis, fatty liver, etc. are helping in the growth of the alcoholic hepatitis therapeutics market. The developments in the technology and science behind it has increased the knowledge about the treatment for the disease, which also leads to the growth of the market.

Alcoholic hepatitis therapeutics manufacturers and research laboratories are collaborating together and this is anticipated to offer significant growth opportunities in the market.

Governments are also backing and various strategies and activities are being performed to diminish ecological contamination and rise in sanitation concerns and the developing oil industry.

The alcoholic hepatitis therapeutics market restrains are increase in the health care expenditure, forceful reimbursement of the policies and greater development cost.

New product launches to flourish the market:

R&D activities have revealed that modification of gut microbiota and products related to it, including nutritional intervention, increasing steroid sensitivity, lipopolysaccharide, immune modulation, and epigenetic modification of liver damage caused by alcohol, are some of the ground breaking avenues in the alcoholic hepatitis therapeutics market that are expected to offer tremendous promise during the forecast period.

In July 2004, Merck Sante s.a.s., the subsidiary of Merck KgaA received an approval for Campral by the FDA. This drug has the potential to treat heavy alcoholism.

In 2006, Endo Laboratories received permission for Vivitrol injection by the FDA. This drug is active against alcohol dependence.

Surge in usage in hospital applications:

Increasing incidence of liver diseases and high success rate of alcoholic hepatitis drugs are some factors that are expected to hike the demand of the global alcoholic hepatitis therapeutics market. Furthermore, increase in awareness about the developments in drugs technology will help the drug usage to surge in the hospital sectors.


Key benefits of the report:

  • This study presents the analytical depiction of the global alcoholic hepatitis therapeutics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global alcoholic hepatitis therapeutics market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global alcoholic hepatitis therapeutics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the alcoholic hepatitis therapeutics market research report:

  • What are the leading market players active in the alcoholic hepatitis therapeutics market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Alcoholic Hepatitis Therapeutics Market Report Highlights

Aspects Details
By Drug Type
  • Corticosteroids
  • Hemorheological agents
  • Anabolic steroids
  • Sulfhydryl agents
  • Monoclonal antibodies
  • Others
By Application
  • Mild disease
  • Severe disease
  • Hospitals
  • Clinics
  • Others
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa
Key Market Players Alkermes Inc., Alfact Innovation, Conatus pharmaceuticals Inc., Dainippon sumitomo pharma Co. ltd., Generon corporation Ltd., Immuron limited, Lupin Laboratories Ltd., Intercept Pharmaceuticals Inc., Teva Pharmaceuticals Ltd., Sanofi-Aventis, Siesta Pharmaceuticals, others.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now









Purchase Full Report of
Alcoholic Hepatitis Therapeutics Market

Start reading.
This Report and over 18,894+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers